DOCS → $28.44 by Jul 30, 2026.

**TL;DR:** Doximity (DOCS) is a digital platform used by 80% of U.S. physicians for collaboration, telehealth, and medical news. They make money by charging pharma companies for targeted marketing access. The stock sold off because pharma clients delayed ad budgets due to regulatory uncertainty around drug pricing (MFN deals). Wall Street panicked, but the fundamentals remain pristine: 89.75% gross margins, 23.59% ROIC, $724M in net cash, and management just authorized a $500M buyback program. Trading at $24 vs. intrinsic value …